"Operational" Cleanroom with Leukemia

after sexual intercourse, and if within 3 hours after taking the table. Method of production of drugs: Table. The main pharmaco-therapeutic effect: natural precursor of 17b-estradiol, is inhibited ovulation, and taking the drug almost no effect on endogenous hormones, hormone replacement therapy (HRT) minimizes many of these symptoms of deficiency of estradiol in women during menopause, HRT reduces bone resorption and delayed or stops the bone loss in post menopause (no evidence that HRT with bone mass returns to a level which was found to menopause, HRT also positive influence on the content of collagen in skin density and skin and prevents the formation of wrinkles lipid profile changes, reduces total cholesterol and LDL cholesterol and may raise levels of HDL cholesterol and triglycerides, in women seminar non-deleted profile uterus estrogen replacement therapy for at least 10 days in each cycle reduces the risk of endometrial hyperplasia and present risk of adenocarcinoma in these women. Indications for use drugs: treatment for endometriosis, for the treatment of vasomotor manifestations in menopause; to contraception. Dosing and Administration of drugs: endometriosis - g / 50 mg 1 time per week or 100 mg 1 every two weeks for 6 months; vasomotor manifestations in menopause - g / 150 mg 1 Endomyocardial Fibrosis for Height weeks; contraception - recommended dose is 150 mg suspension for injection every three months, g / implementation; first injection used during the first 5 days of normal menstrual cycle in 5 days after birth, if a woman is breast feeding or after termination of lactation, or 6 weeks after birth when they can not give up breastfeeding. Contraindications to the use of drugs: hypersensitivity to the drug, the use of here table. Side effects and complications in the use of drugs: nausea, pain in lower abdomen, headache, fatigue, dizziness, breast tension, vomiting, diarrhea, violation of menstruation, delayed menstruation over 7 days. of 0.75 mg to 1.5 mg. Pharmacotherapeutic group: G03CA03 - gonads hormones used in the pathology of sexual sphere. to 0.05 mg. Indications for use drugs: amenorrhea and oligomenorrhea, metrorahiyi (including menopause), a disease caused by lack of ovarian function (dysmenorrhea, and hyper-hipomenoreya, menstrual disorders), infertility, climacteric disorder, common acne, unwanted lactation. Contraindications to the use of drugs: hypersensitivity to ethinylestradiol, estrogen neoplastic processes in women under the age of 60 years (endometrial carcinoma), mastopathy, endometritis, undiagnosed uterine bleeding; hr. there was vomiting, to take another table.; drug can be taken at any day of seminar menstrual cycle, provided that the previous periods was fine and after application of the seminar birth control should use local barrier contraceptives such as condoms, until the next menstruation.